NSF/FDA SIR: Using Microbial Signaling Systems to Understand Relationship Between Microbial Growth an d Breast Implant Complications

NSF/FDA SIR:利用微生物信号系统了解微生物生长与乳房植入物并发症之间的关系

基本信息

  • 批准号:
    2037572
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2022-09-30
  • 项目状态:
    已结题

项目摘要

Breast augmentation is one of the most popular surgical cosmetic procedures nationwide, with over $1.1 billion spent on silicone gel implants in 2018. However, breast implants are not lifetime devices and the longer patients have breast implants, the higher the risk of complications. Recent studies show that biofilms, microbial communities that grow on surfaces, are associated with these complications. At the center of the discussion is BIA-ALCL (breast implant-associated anaplastic large cell lymphoma/cancer) which recently triggered a series of regulatory actions worldwide. Recent studies suggest that the higher surface area of textured implants provide more opportunity for bacteria to colonize into biofilms, which could stimulate a cascade of immune responses including chronic inflammation, one of the possible pathogenesis of BIA-ALCl. The goal of this one-year Scholar-in-Residence project is to study the impact of a special set of molecules known to regulate bacteria activity, termed “quorum sensing molecules," on BIA-ALCL. The project’s findings are expected to provide information that aids in the review of new strategies to control and inhibit bacterial infection in breast implants. These findings will also be integrated into existing K-12 outreach activities occurring at Howard Middle School. This proposed research will support a female graduate student from Howard University engaged in highly interdisciplinary research and a new collaboration between Howard University and the Food and Drug Administration.This project is focused on the impact of quorum sensing (QS) molecules on BIA-ALCL. Microbial communities use QS molecules to coordinate microbial community function. QS molecules are often used to regulate biofilm formation and can be associated with a T-Cell response in certain types of organisms, though current knowledge on immune response to QS molecules is nascent. The research plan is designed to advance knowledge on the link between microbial community quorum sensing capacity and malignancies. The central hypothesis of this work is that QS can regulate biofilm formation in textured implants. The investigators will employ bioinformatic, experimental, and computational models to assess this hypothesis with three objectives: (1) Conduct a review and bioinformatic analysis on breast implant microbiota, (2) Develop a drip flow biofilm reactor system to evaluate how biofilms response to molecular cues, and (3) Develop a computational model system to evaluate how biofilms respond to material cues. The expected outcome is an understanding of differences in the microbial structure and function as it relates to quorum sensing capacity in implants of different patients. The bioinformatics analysis could serve as a case study on how to utilize high-throughput tools to facilitate regulatory review of permanent implants. The model system will provide information that aids in the review of new strategies to control and inhibit bacterial infection in breast implants.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
隆胸是全国最受欢迎的外科美容手术之一,2018年在硅凝胶植入物上花费了超过11亿美元。然而,乳房植入体不是终身设备,患者使用乳房植入体的时间越长,并发症的风险就越高。最近的研究表明,生物膜,表面上生长的微生物群落,与这些并发症有关。讨论的中心是BIA-ALCL(乳腺植入物相关的间变性大细胞淋巴瘤/癌症),最近在全球范围内引发了一系列监管行动。最近的研究表明,毛面植入物的更高表面积为细菌定植到生物膜中提供了更多机会,这可能刺激一系列免疫反应,包括慢性炎症,这是BIA-ALCl的可能发病机制之一。 这个为期一年的驻校学者项目的目标是研究一组已知调节细菌活性的特殊分子(称为“群体感应分子”)对BIA-ALCL的影响。 该项目的研究结果有望提供信息,有助于审查控制和抑制乳房植入体细菌感染的新策略。这些调查结果也将被纳入现有的K-12外展活动发生在霍华德中学。这项研究将支持霍华德大学的一名女研究生从事高度跨学科的研究,以及霍华德大学和美国食品药品监督管理局之间的一项新合作。该项目的重点是群体感应(QS)分子对BIA-ALCL的影响。微生物群落利用QS分子协调微生物群落功能。QS分子通常用于调节生物膜的形成,并且可以与某些类型的生物体中的T细胞应答相关,尽管目前关于对QS分子的免疫应答的知识是新生的。该研究计划旨在提高对微生物群落群体感应能力与恶性肿瘤之间联系的认识。这项工作的中心假设是,QS可以调节毛面种植体中的生物膜形成。研究人员将采用生物信息学、实验和计算模型来评估这一假设,目标有三个:(1)对乳房植入体微生物群进行审查和生物信息学分析,(2)开发滴流生物膜反应器系统,以评估生物膜如何对分子线索做出反应,以及(3)开发计算模型系统,以评估生物膜如何对材料线索做出反应。预期的结果是了解微生物结构和功能的差异,因为它涉及到不同患者植入物的群体感应能力。 生物信息学分析可以作为如何利用高通量工具促进永久性植入物监管审查的案例研究。该模型系统将提供信息,帮助审查新的战略,以控制和抑制细菌感染的乳房implants.This奖项反映了NSF的法定使命,并已被认为是值得通过评估使用基金会的智力价值和更广泛的影响审查标准的支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeseth Delgado Vela其他文献

Metagenomic Analysis of the Antibiotic Resistance Risk between an Aerobic and Anaerobic Membrane Bioreactor
好氧和厌氧膜生物反应器之间抗生素耐药性风险的宏基因组分析
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Phillip Wang;Ali Zarei;Jeseth Delgado Vela;Adam L. Smith
  • 通讯作者:
    Adam L. Smith
Elucidating the impact of microbial community biodiversity on pharmaceutical biotransformation during wastewater treatment
阐明废水处理过程中微生物群落生物多样性对药物生物转化的影响
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    L. Stadler;Jeseth Delgado Vela;Sunit Jain;G. Dick;N. Love
  • 通讯作者:
    N. Love

Jeseth Delgado Vela的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeseth Delgado Vela', 18)}}的其他基金

Collaborative Research: URoL:ASC: Determining the relationship between genes and ecosystem processes to improve biogeochemical models for nutrient management
合作研究:URoL:ASC:确定基因与生态系统过程之间的关系,以改进营养管理的生物地球化学模型
  • 批准号:
    2319124
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
CAREER: Quorum enhanced sustainable treatment of nitrogen (QuEST-N)
职业:群体强化可持续氮处理 (QuEST-N)
  • 批准号:
    2349328
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
CAREER: Quorum enhanced sustainable treatment of nitrogen (QuEST-N)
职业:群体强化可持续氮处理 (QuEST-N)
  • 批准号:
    2143410
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant

相似国自然基金

FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
  • 批准号:
    82373165
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
多维互质结构FDA雷达稀疏空时距自适应处理研究
  • 批准号:
    61771317
  • 批准年份:
    2017
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
  • 批准号:
    81573740
  • 批准年份:
    2015
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目

相似海外基金

NSF/FDA SiR: Pulse Oximetry Measurement Errors Correlated with Patient Skin Pigmentation: Optical Mechanisms and Effect Multipliers
NSF/FDA SiR:与患者皮肤色素沉着相关的脉搏血氧饱和度测量误差:光学机制和效应乘数
  • 批准号:
    2229356
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF FDA/SiR: Development of eeDAP microscopy platform software, validation data, and statistical methods to assess performance of candidate Software as a Medical Device (SaMD)
NSF FDA/SiR:开发 eeDAP 显微镜平台软件、验证数据和统计方法,以评估候选软件作为医疗设备 (SaMD) 的性能
  • 批准号:
    2326317
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SiR: A Nonclinical Testing Tool for Wearable Photoplethysmography-Based Blood Pressure Monitoring Devices
NSF/FDA SiR:用于基于光电体积描记法的可穿戴血压监测设备的非临床测试工具
  • 批准号:
    2325722
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SiR: Validation and Standardization of Melanometry as a Quantitative Tool for Clinical Evaluation of Racial Disparities in Biophotonic Devices
NSF/FDA SiR:黑素测定法作为生物光子设备种族差异临床评估定量工具的验证和标准化
  • 批准号:
    2326485
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Robust, Reliable, and Trustworthy Regulatory Science Tool for Stroke Recovery Assessment using Hybrid Brain-Muscle Functional Coupling Analysis
NSF/FDA SIR:使用混合脑-肌肉功能耦合分析进行中风恢复评估的稳健、可靠且值得信赖的监管科学工具
  • 批准号:
    2229697
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: 3D Human Stem Cell Cardiac Model for Cardiac Electrophysiology Medical Device Safety Assessment
NSF/FDA SIR:用于心脏电生理学医疗器械安全评估的 3D 人体干细胞心脏模型
  • 批准号:
    2129369
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Towards the Establishment of a Validation Framework for Wearable Motion Analysis Systems: Development and Evaluation of an Open-Design Sync Platform
NSF/FDA SIR:建立可穿戴运动分析系统的验证框架:开放式设计同步平台的开发和评估
  • 批准号:
    2229538
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Assessing the Photocytotoxicity and Photochemistry of New Emerging Fluorophores
NSF/FDA SIR:评估新兴荧光团的光细胞毒性和光化学
  • 批准号:
    2037815
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Designing for Degradation: A framework for Predicting in vivo Degradation and Mechanical Property Changes in Degradable Polymers
NSF/FDA SIR:降解设计:预测可降解聚合物体内降解和机械性能变化的框架
  • 批准号:
    2129615
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Numerical heart model for irreversible electroporation ablation
NSF/FDA SIR:不可逆电穿孔消融的数字心脏模型
  • 批准号:
    2129626
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了